EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

World Journal of Surgical Oncology

ISSN 1477-7819 · Springer Science and Business Media LLC

Latest articles

  1. Gemcitabine plus cisplatin versus gemcitabine as adjuvant therapy after curative-intent resection of cholangiocarcinoma (GeCiCCA): a multicenter, randomized controlled, phase III trial

    Aumkhae Sookprasert, Attapol Titapun, Kosin Wirasorn, Piyakarn Watcharenwong, Thanachai Sanlung, Chaiyut Charoentum, Chawalit Chayangsu, Julaluck Promsorn, Kulyada Eurboonyanan, Piti Ungarreevittaya, Vor Luvira, Tharatip Srisuk, Apiwat Jarearnrat, Watcharin Loilome, Jarin Chindaprasirt

    Published: 2026-11-06DOI: 10.1186/s12957-026-04637-4

Volumes

2026 · 4732025 · 5202024 · 3542023 · 3932022 · 4092021 · 3502020 · 3312019 · 2322018 · 2412017 · 2312016 · 2792015 · 3682014 · 4072013 · 3152012 · 2822011 · 1742010 · 1142009 · 1022008 · 1392007 · 1462006 · 972005 · 782004 · 472003 · 30

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.